Effect of probucol treatment on malondialdehyde-modified low-density lipoproteins in type 2 diabetic patients with hypercholesterolemia.

被引：0

作者：

Iijima, H ^{[1
]}

Sato, N ^{[1
]}

Motohashi, S ^{[1
]}

Kase, H ^{[1
]}

Kawagoe, Y ^{[1
]}

Matsumura, M ^{[1
]}

Atsuta, H ^{[1
]}

Enomoto, M ^{[1
]}

Kato, T ^{[1
]}

Mochizuki, Y ^{[1
]}

Kanazawa, H ^{[1
]}

Kuroda, H ^{[1
]}

Bannba, N ^{[1
]}

Hattori, Y ^{[1
]}

Kasai, K ^{[1
]}

机构：

[1] Dokkyo Univ, Sch Med, Dept Endocrinol & Metab, Mibu, Tochigi, Japan

来源：

DIABETOLOGIA | 2001年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1229

引用

页码：A320 / A320

页数：1

共 50 条

[31] Fenofibrate therapy improves postprandial responses to fat and malondialdehyde-modified low-density lipoprotein (MDA-LDL) levels in diabetic and non-diabetic patients with hypertriglyceridemia
Sone, H
Saito, K
Ito, S
Kobayashi, K
Takahashi, A
Iida, KT
Shimano, H
Suzuki, H
Toyoshima, H
Okuda, Y
Yamada, N
ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 176 - 176
[32] EFFECT OF PROBUCOL ON THE PHYSICAL-PROPERTIES OF LOW-DENSITY LIPOPROTEINS OXIDIZED BY COPPER
MCLEAN, LR
HAGAMAN, KA
BIOCHEMISTRY, 1989, 28 (01) : 321 - 327
[33] THE METABOLISM OF VERY LOW-DENSITY AND INTERMEDIATE DENSITY LIPOPROTEINS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
SOUTAR, AK
MYANT, NB
THOMPSON, GR
ATHEROSCLEROSIS, 1982, 43 (2-3) : 217 - 231
[34] Increased circulating malondialdehyde-modified low-density lipoprotein levels in patients with ergonovine-induced coronary artery spasm
Ito, Tsuyoshi
Fujita, Hiroshi
Tani, Tomomitsu
Sugiura, Tomonori
Ohte, Nobuyuki
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 475 - 480
[35] TREATMENT OF HOMOZYGOTIC FAMILIAL HYPERCHOLESTEROLEMIA WITH CONTINUOUS APHERESIS OF LOW-DENSITY LIPOPROTEINS
TERUEL, JL
LASUNCION, MA
CASTANON, MA
GALLEGO, N
HERRERA, E
ORTUNO, J
MEDICINA CLINICA, 1991, 97 (19): : 738 - 740
[36] TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA BY PRECIPITATION OF LOW-DENSITY LIPOPROTEINS WITH DEXTRAN SULFATE
ANTWILER, GD
DAU, PC
LOBDELL, DD
ARTIFICIAL ORGANS, 1988, 12 (04) : 351 - 351
[37] Unsaturated fatty acids with association with elevation of malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a marker of oxidized low-density lipoprotein
Mori, T.
Tanno, Y.
Kasakura, S.
Yosioka, K.
Nakai, N.
CEREBROVASCULAR DISEASES, 2017, 43
[38] Antibodies against copper-oxidised and malondialdehyde-modified low density lipoproteins in pre-eclamptic pregnancies
Uotila, J
Solakivi, T
Jaakkola, O
Tuimala, R
Lehtimäki, T
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (10): : 1113 - 1117
[39] EFFECT OF FEBUXOSTAT ON THE LEVEL OF MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEIN, AS AN OXIDANT MARKER, FROM THE SUB-ANALYSES OF PRIZE STUDY
Teragawa, Hiroki
Tanaka, Atsushi
Fujii, Yuichi
Ueda, Tomohiro
Nomura, Shuichi
Node, Koichi
JOURNAL OF HYPERTENSION, 2023, 41 : E477 - E477
[40] PLATELET-MODIFIED LOW-DENSITY LIPOPROTEINS - STUDIES IN NORMAL SUBJECTS AND IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
AVIRAM, M
CLINICAL BIOCHEMISTRY, 1987, 20 (02) : 91 - 95

← 1 2 3 4 5 →